妊娠滋养细胞疾病诊断与治疗指南(2021年版)

2021-06-25 中国抗癌协会妇科肿瘤专业委员会 中国癌症杂志.2021.31(6):520-532.

妊娠滋养细胞疾病(gestational trophoblastic disease,GTD)是一组来源于胎盘滋养细胞的疾病,包括良性的葡萄胎及恶性滋养细胞疾病等。目前,国际上有多个GTD诊

中文标题:

妊娠滋养细胞疾病诊断与治疗指南(2021年版)

发布日期:

2021-06-25

简要介绍:

妊娠滋养细胞疾病(gestational trophoblastic disease,GTD)是一组来源于胎盘滋养细胞的疾病,包括良性的葡萄胎及恶性滋养细胞疾病等。目前,国际上有多个GTD诊治的指南。本指南旨在制定针对中国该疾病诊断、治疗和随访的策略。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=妊娠滋养细胞疾病诊断与治疗指南(2021年版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=26c6c1c00212e0c3, title=妊娠滋养细胞疾病诊断与治疗指南(2021年版), enTitle=, guiderFrom=中国癌症杂志.2021.31(6):520-532., authorId=0, author=, summary=妊娠滋养细胞疾病(gestational trophoblastic disease,GTD)是一组来源于胎盘滋养细胞的疾病,包括良性的葡萄胎及恶性滋养细胞疾病等。目前,国际上有多个GTD诊, cover=https://img.medsci.cn/2021711/1626015998705_2020535.jpg, journalId=0, articlesId=null, associationId=1526, associationName=中国抗癌协会妇科肿瘤专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Fri Jun 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>妊娠滋养细胞疾病(gestational trophoblastic&nbsp;disease,GTD)是一组来源于胎盘滋养细胞的疾病,包括良性的葡萄胎及恶性滋养细胞疾病等。目前,国际上有多个GTD诊治的指南。本指南旨在制定针对中国该疾病诊断、治疗和随访的策略。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=37155, tagName=妊娠滋养细胞疾病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=37155, guiderKeyword=妊娠滋养细胞疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4634, appHits=195, showAppHits=0, pcHits=593, showPcHits=4377, likes=2, shares=22, comments=14, approvalStatus=1, publishedTime=Sun Jul 11 23:16:31 CST 2021, publishedTimeString=2021-06-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 11 23:06:45 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 16:33:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=妊娠滋养细胞疾病诊断与治疗指南(2021年版).pdf)])
妊娠滋养细胞疾病诊断与治疗指南(2021年版).pdf
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220032, encodeId=1792122003259, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68ad8159551, createdName=ms6000000965463059, createdTime=Mon May 16 15:25:00 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202497, encodeId=cb32120249eaf, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:02:29 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079795, encodeId=104b10e97951b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Tue Dec 14 07:48:59 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079673, encodeId=83f210e9673ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/725901dc0ed249ebba9d096aacddde3f/a89b874e17434adb82b0c2dff5f374f1.jpg, createdBy=c0225555986, createdName=@gxl, createdTime=Mon Dec 13 20:22:54 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079669, encodeId=b3f610e966910, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5f65179144, createdName=146f2224m16暂无昵称, createdTime=Mon Dec 13 20:14:46 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2022-05-16 ms6000000965463059

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1220032, encodeId=1792122003259, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68ad8159551, createdName=ms6000000965463059, createdTime=Mon May 16 15:25:00 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202497, encodeId=cb32120249eaf, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:02:29 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079795, encodeId=104b10e97951b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Tue Dec 14 07:48:59 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079673, encodeId=83f210e9673ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/725901dc0ed249ebba9d096aacddde3f/a89b874e17434adb82b0c2dff5f374f1.jpg, createdBy=c0225555986, createdName=@gxl, createdTime=Mon Dec 13 20:22:54 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079669, encodeId=b3f610e966910, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5f65179144, createdName=146f2224m16暂无昵称, createdTime=Mon Dec 13 20:14:46 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2022-03-14 ms4000001244815732

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1220032, encodeId=1792122003259, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68ad8159551, createdName=ms6000000965463059, createdTime=Mon May 16 15:25:00 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202497, encodeId=cb32120249eaf, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:02:29 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079795, encodeId=104b10e97951b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Tue Dec 14 07:48:59 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079673, encodeId=83f210e9673ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/725901dc0ed249ebba9d096aacddde3f/a89b874e17434adb82b0c2dff5f374f1.jpg, createdBy=c0225555986, createdName=@gxl, createdTime=Mon Dec 13 20:22:54 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079669, encodeId=b3f610e966910, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5f65179144, createdName=146f2224m16暂无昵称, createdTime=Mon Dec 13 20:14:46 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-14 Arwen_Lau

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1220032, encodeId=1792122003259, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68ad8159551, createdName=ms6000000965463059, createdTime=Mon May 16 15:25:00 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202497, encodeId=cb32120249eaf, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:02:29 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079795, encodeId=104b10e97951b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Tue Dec 14 07:48:59 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079673, encodeId=83f210e9673ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/725901dc0ed249ebba9d096aacddde3f/a89b874e17434adb82b0c2dff5f374f1.jpg, createdBy=c0225555986, createdName=@gxl, createdTime=Mon Dec 13 20:22:54 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079669, encodeId=b3f610e966910, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5f65179144, createdName=146f2224m16暂无昵称, createdTime=Mon Dec 13 20:14:46 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-13 @gxl

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1220032, encodeId=1792122003259, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68ad8159551, createdName=ms6000000965463059, createdTime=Mon May 16 15:25:00 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202497, encodeId=cb32120249eaf, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:02:29 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079795, encodeId=104b10e97951b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Tue Dec 14 07:48:59 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079673, encodeId=83f210e9673ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210724/725901dc0ed249ebba9d096aacddde3f/a89b874e17434adb82b0c2dff5f374f1.jpg, createdBy=c0225555986, createdName=@gxl, createdTime=Mon Dec 13 20:22:54 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079669, encodeId=b3f610e966910, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5f65179144, createdName=146f2224m16暂无昵称, createdTime=Mon Dec 13 20:14:46 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-13 146f2224m16暂无昵称

    谢谢分享

    0